簡易グラフ
詳細なスケジュール
説明 Tema Oncology ETF
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.| Assets class size | Multi-Cap |
|---|---|
| Country | USA |
| Country ISO | US |
| Focus | Health Care |
| Issuer | Tema Global Ltd. |
| Region specific | Broad |
| Segment | Equity: Global Pharma, Biotech & Life Sciences |
| Strategy | Active |
| Валюта | usd |
| Годовая доходность | 30.23 |
| Дата основания | Aug 15. 2023 |
| Див доходность | 0.55 |
| Индекс | ACTIVE - No Index |
| Количество компаний | 10 |
| Комиссия | 0.75 |
| Полное наименование | Tema Oncology ETF |
| Регион | Global |
| Сайт | リンク |
| Средний P/E | 16.57 |
| Тип актива | Equity |
| 1日あたりの価格変動: | 0% (24.955) |
|---|---|
| 週ごとの価格変動: | -1.69% (25.385) |
| 月ごとの料金変更: | -3.65% (25.9) |
| 3ヶ月間の価格変動: | +1.18% (24.665) |
| 半年間の価格変動: | -12.19% (28.42) |
| 年初からの価格変動: | +2.89% (24.255) |
サブスクリプションの料金を支払う
サブスクリプションにより、企業およびポートフォリオ分析のためのより多くの機能とデータを利用できます
| 名前 | 業界 | 共有, % | P/BV | P/S | P/E | EV/Ebitda | 配当利回り |
|---|---|---|---|---|---|---|---|
 Regeneron |
Healthcare | 6.0665 | 3.71 | 7.34 | 24.35 | 23.78 | 0.1276 |
 AstraZeneca PLC |
Healthcare | 5.94354 | 2.49 | 1.88 | 14.45 | 7.38 | 1.96 |
 Merck & Co |
Healthcare | 4.26457 | 7.29 | 4.56 | 751.54 | 40.3 | 2.77 |
 argenx SE |
Healthcare | 4.19048 | 5.2 | 17.38 | 0 | -87.37 | 0 |
 Daiichi Sankyo Company, Limited |
Healthcare | 3.81885 | 5.48 | 5.78 | 46.09 | 29.44 | 1.54 |
 Amgen |
Healthcare | 3.775 | 24.53 | 5.42 | 22.76 | 26.16 | 2.91 |
 Chugai Pharmaceutical Co., Ltd. |
Healthcare | 3.57457 | 5.41 | 7.92 | 27.04 | 18.68 | 2.06 |
 Blueprint Medicines Corporation |
Healthcare | 3.30318 | 41.19 | 21.57 | 15.98 | -12.82 | 0 |
 Illumina |
Healthcare | 3.27465 | 3.85 | 4.86 | 39.92 | -21.83 | 0 |
 Revolution Medicines, Inc. |
Healthcare | 3.12948 | 1.79 | 282.39 | 0 | -5.57 | 0 |
| 41.32 | 10.09 | 35.91 | 94.21 | 1.81 | 1.14 |
